Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK, Curry CV, Allen CE.
Br J Haematol. 2022 Jan;196(1):31-44. doi: 10.1111/bjh.17638. Epub 2021 Jun 24.
Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS, Oon ML, Wang S, Tan SY, Ng SB.
Pathology. 2020 Jan;52(1):111-127. doi: 10.1016/j.pathol.2019.09.011. Epub 2019 Nov 22.
Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency.
Martin E, Winter S, Garcin C, Tanita K, Hoshino A, Lenoir C, Fournier B, Migaud M, Boutboul D, Simonin M, Fernandes A, Bastard P, Le Voyer T, Roupie AL, Ben Ahmed Y, Leruez-Ville M, Burgard M, Rao G, Ma CS, Masson C, Soudais C, Picard C, Bustamante J, Tangye SG, Cheikh N, Seppänen M, Puel A, Daly M, Casanova JL, Neven B, Fischer A, Latour S.
Nature. 2024 Apr;628(8008):620-629. doi: 10.1038/s41586-024-07213-6. Epub 2024 Mar 20.
Chronic Active Epstein-Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
Fujiwara S, Nakamura H.
Cancers (Basel). 2020 Oct 30;12(11):3202. doi: 10.3390/cancers12113202.
Virus-triggered secondary hemophagocytic lymphohistiocytosis.
Imashuku S, Morimoto A, Ishii E.
Acta Paediatr. 2021 Oct;110(10):2729-2736. doi: 10.1111/apa.15973. Epub 2021 Jun 22.
Severe chronic active Epstein-Barr virus infection syndrome.
Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT.
Clin Microbiol Rev. 1991 Jan;4(1):129-35. doi: 10.1128/CMR.4.1.129.
Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
Xiao H, Hu B, Luo R, Hu H, Zhang J, Kuang W, Zhang R, Li L, Liu G.
Virol J. 2020 Oct 29;17(1):166. doi: 10.1186/s12985-020-01409-8.
Chronic active Epstein-Barr virus enteritis: A literature review.
Shen Y, Wang YF.
J Dig Dis. 2022 May;23(5-6):248-252. doi: 10.1111/1751-2980.13097. Epub 2022 Jun 16.
Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.
Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure.
J Clin Exp Hepatol. 2020 Jul-Aug;10(4):339-376. doi: 10.1016/j.jceh.2020.04.012. Epub 2020 Apr 28.
Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome.
Okano M.
Crit Rev Oncol Hematol. 2002 Dec;44(3):273-82. doi: 10.1016/s1040-8428(02)00118-x.
